Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Role of TLRs in HIV-1 Infection and Potential of TLR Agonists in HIV-1 Vaccine Development and Treatment Strategies (CROSBI ID 323576)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Rozman, Marija ; Zidovec Lepej, Snjezana ; Jambrosic Karlo ; Babić, Maja ; Hofman Drmić, Irena Role of TLRs in HIV-1 Infection and Potential of TLR Agonists in HIV-1 Vaccine Development and Treatment Strategies // Pathogens, 12 (2023), 92, 22. doi: 10.3390/pathogens12010092

Podaci o odgovornosti

Rozman, Marija ; Zidovec Lepej, Snjezana ; Jambrosic Karlo ; Babić, Maja ; Hofman Drmić, Irena

engleski

Role of TLRs in HIV-1 Infection and Potential of TLR Agonists in HIV-1 Vaccine Development and Treatment Strategies

Toll-like receptors (TLRs), as a family of pattern recognition receptors, play an important role in the recognition of HIV-1 molecular structures by various cells of the innate immune system, but also provide a functional association with subsequent mechanisms of adaptive immunity. TLR7 and TLR8 play a particularly important role in the innate immune response to RNA viruses due to their ability to recognise GU-rich single-stranded RNA molecules and subsequently activate intracellular signalling pathways resulting in expression of genes coding for various biological response modifiers (interferons, proinflammatory cytokines, chemokines). The aim of this review is to summarise the most recent knowledge on the role of TLRs in the innate immune response to HIV-1 and the role of TLR gene polymorphisms in the biology and in the clinical aspects of HIV infections. In addition, the role of TLR agonists as latency reversing agents in research to treat HIV infections and as immunomodulators in HIV vaccine research will be discussed.

HIV-1 ; TLR agonists ; Toll-like receptors (TLRs) ; innate immunity ; latency reversing agents (LRAs).

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

12

2023.

92

22

objavljeno

2076-0817

10.3390/pathogens12010092

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost